Aggressive · Stocks to Consider and Updates

Allocation Update – Aggressive Portfolio

Continuing with re-allocations of the three buttonwoodproject portfolios, today I am updating the aggressive candidate list. Increases to the allocation model include . . . . . . the iShares MSCI Emerging Markets Fund that tracks an index that includes about one-thousand companies that are based in emerging economic markets. Although well diversified, it is overweight… Continue reading Allocation Update – Aggressive Portfolio

Income · Stocks to Consider and Updates

J&J to Acquire Taris Biomedical and Completes Stake in Verb Surgical

Health care giant Johnson & Johnson (NYSE: JNJ - $146.06) said it is acquiring Taris Biomedical LLC, a privately owned biotech company focusing on a drug-delivery device for the treatment of bladder diseases, including cancer. The silicone delivery device allows for the continued release of medication into the bladder, the company said. Taris will become… Continue reading J&J to Acquire Taris Biomedical and Completes Stake in Verb Surgical

Income · Stocks to Consider and Updates

Allocation Update – Income Portfolio

As I posted yesterday in the conservative portfolio update, I am also makings a few minor changes to the income candidate list to better reflect what I see as opportunities and headwinds in 2020. While the portfolio itself remains unchanged, I am tweaking the percentage allocations as follows: On the plus side is CVS Health,… Continue reading Allocation Update – Income Portfolio

Conservative · Stocks to Consider and Updates

Allocation Update – Conservative Portfolio

Looking ahead into 2020, I am making some allocation moves for the conservative portfolio that should better reflect the expected changes to the economy including interest rates and trade and to mitigate the risk of high valuations. I like what I am seeing in the restructuring at ABB with new management and the sale of… Continue reading Allocation Update – Conservative Portfolio

Aggressive · Stocks to Consider and Updates

Jabil Posts Strong Results; Lifts Full-Year Guidance

Shares of contract electronics manufacturer Jabil, Inc. (NYSE: JBL - $42.68) are trading higher by about 5% on better-than-expected fiscal first-quarter financial results and an updated outlook for the full fiscal year ending in August 2020. Revenue for the period was $7.5 billion, up 15.4% from a year earlier, and above the previous guidance range… Continue reading Jabil Posts Strong Results; Lifts Full-Year Guidance